Merck Research Laboratories

Latest stories

4d
PharmaceuticalOnline
OneSource’s Lab And IT Skills Enable Fast Efficient Upgrade Of Merck Lab Computing EnvironmentAfter its parent Merck® merged with Schering-Plough, Merck Research Laboratorie
OneSource’s Lab And IT Skills Enable Fast Efficient Upgrade Of Merck Lab Computing Environment
PharmaceuticalOnline / Posted 4 days ago
After its parent Merck® merged with Schering-Plough, Merck Research Laboratories (MRL) found itself with differing lab computing models and standards including many outdated systems with data communications and security issues. The MRL information... Read more
5d
Business Wire
Merck Announces Fourth-Quarter and Full-Year 2015 Financial ResultsKENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the U
Merck Announces Fourth-Quarter and Full-Year 2015 Financial Results
Business Wire / Posted 5 days ago
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2015. “The past year was one of considerable progress and execution for... Read more
45 related stories
10d
Business Wire
Merck Receives FDA Approval of ZEPATIER™ (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority ReviewKENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the U
Merck Receives FDA Approval of ZEPATIER™ (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review
Business Wire / Posted 10 days ago
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved ZEPATIER™ (elbasvir and grazoprevir) for the treatment of adult... Read more
19d
News-Medical-Net
Study outlines new model to help predict age-related response to hepatitis B vaccinePhysicians have known for years that patients respond differently to vaccines a
Study outlines new model to help predict age-related response to hepatitis B vaccine
News-Medical-Net / Posted 19 days ago
Physicians have known for years that patients respond differently to vaccines as they age. There may soon be a new way to predict and enhance the effectiveness of vaccinations, in particular the hepatitis B vaccine. Researchers at Case Western... Read more
28d
Business Wire
Merck Acquires IOmet Pharma and Expands Immuno-Oncology Development ProgramKENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the
Merck Acquires IOmet Pharma and Expands Immuno-Oncology Development Program
Business Wire / Posted 28 days ago
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that it has acquired IOmet, a privately-held UK-based drug discovery company focused on the development of innovative medicines... Read more

People in this news